Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

The new era of anticoagulation: factor XI and XII inhibitors

Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol

07-06-2023

https://doi.org/10.4081/btvb.2023.76

2136

PDF: 857
Allopurinol-induced acquired von Willebrand syndrome

Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

25-10-2023

https://doi.org/10.4081/btvb.2023.88

1582

PDF: 185
Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz

16-05-2024

https://doi.org/10.4081/btvb.2024.118

776

PDF: 301
A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

09-03-2023

https://doi.org/10.4081/btvb.2023.53

680

PDF: 348
The von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

26-04-2022

https://doi.org/10.4081/btvb.2022.11

1996

PDF: 347
Recent advances in classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, spontaneous HIT, and vaccine-induced immune thrombotic thrombocytopenia

Bianca Clerici, Mariangela Scavone, Gian Marco Podda

20-06-2024

https://doi.org/10.4081/btvb.2024.127

1881

PDF: 508
Growing weapons to fight hemophilia

Pier Mannuccio Mannucci

23-02-2023

https://doi.org/10.4081/btvb.2023.64

755

PDF: 307
Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

03-08-2023

https://doi.org/10.4081/btvb.2023.90

1366

PDF: 454
Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

14-12-2022

https://doi.org/10.4081/btvb.2022.50

791

PDF: 308
The changing landscape of treatment for acquired hemophilia A

Massimo Franchini, Daniele Focosi

30-01-2025

https://doi.org/10.4081/btvb.2025.157

788

PDF: 258
Is non-alcoholic fatty liver disease a prothrombotic risk factor?

Niccolò Bitto, Vincenzo La Mura, Anna Ludovica Fracanzani, Armando Tripodi

19-05-2023

https://doi.org/10.4081/btvb.2023.81

596

PDF: 190
Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

22-04-2024

https://doi.org/10.4081/btvb.2024.104

412

PDF: 131
Safety of COVID-19 mRNA vaccination in patients with history of acquired hemophilia A: a case series

Luca Puccetti, Vincenzo Sammartano, Federico Caroni, Margherita Malchiodi, Paola Calzoni, Eleonora Franceschini, Lucrezia Galasso, Monica Bocchia

17-10-2022

https://doi.org/10.4081/btvb.2022.40

2386

PDF: 223
Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications

Federica Azzolini, Antonio Bruno, Ettore Dolcetti, Diego Centonze, Fabio Buttari

03-05-2023

https://doi.org/10.4081/btvb.2023.66

1031

PDF: 226
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

15-04-2022

https://doi.org/10.4081/btvb.2022.22

2007

PDF: 528
It’s definitely time to consider diet in its ultra-processing form as a major risk factor for thrombotic vascular disorders

Marialaura Bonaccio, Licia Iacoviello, Maria Benedetta Donati

03-08-2023

https://doi.org/10.4081/btvb.2023.91

1105

PDF: 213
An ecological alliance against air pollution and cardiovascular disease

Pier Mannuccio Mannucci

22-03-2022

https://doi.org/10.4081/btvb.2022.21

1735

PDF: 279
Management of atrial fibrillation: a practical and useful synopsis of last guidelines

Gualtiero Palareti

24-02-2025

https://doi.org/10.4081/btvb.2025.168

698
Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares

16-05-2024

https://doi.org/10.4081/btvb.2024.114

486

PDF: 179
Importance of assessment of carotid plaques in the managementof acute ischemic stroke: floating intracarotid plaque

Marwa Eltemamy, Robert Namushi, Narayanamoorthi Saravanan

06-09-2023

https://doi.org/10.4081/btvb.2023.79

598

PDF: 171
Coagulome and tumor microenvironment: impact of oncogenes, cellular heterogeneity and extracellular vesicles

Nadim Tawil, Lata Adnani, Janusz Rak

16-05-2024

https://doi.org/10.4081/btvb.2024.109

405

PDF: 161
Association between non-O blood type and early unexplained recurrent spontaneous abortion in women with and without inherited thrombophilia

Anna Poretto, Elisabetta Borella, Giacomo Turatti, Michelangelo Marobin, Elena Campello, Daniela Tormene, Paolo Simioni, Luca Spiezia

14-11-2022

https://doi.org/10.4081/btvb.2022.47

1159

PDF: 216
Vasculopathy: a possible factor affecting hereditary angioedema

Anna Laura Colia, Alessandra Ranaldi, Rosa Santacroce, Giovanna D'Andrea, Angela Bruna Maffione, Maurizio Margaglione, Maria D'Apolito

04-02-2025

https://doi.org/10.4081/btvb.2025.152

539

pdf: 185
Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

Sarah Gallitto, Thomas C. Varkey, Jacob Lahti

13-12-2024

https://doi.org/10.4081/btvb.2024.131

1092

PDF: 179
Influence of emicizumab on protein C-mediated clotting regulation

Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

25-10-2023

https://doi.org/10.4081/btvb.2023.89

1967

PDF: 224

Supplementary Material: 45
Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò

23-05-2022

https://doi.org/10.4081/btvb.2022.23

3726

PDF: 262
The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

04-09-2024

https://doi.org/10.4081/btvb.2024.144

863

PDF: 197

SUPPLEMENTARY MATERIAL: 92

1 - 27 of 27 items

© PAGEPress 2008-2025 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy